Gainers
- Kiora Pharmaceuticals KPRX stock rose 48.3% to $0.82 during Thursday's pre-market session. The company's market cap stands at $6.2 million.
- Salarius Pharmaceuticals SLRX stock rose 25.68% to $0.69. The market value of their outstanding shares is at $2.7 million.
- HOOKIPA Pharma HOOK shares rose 20.59% to $0.75. The market value of their outstanding shares is at $74.1 million.
- Eterna Therapeutics ERNA stock rose 19.16% to $1.99. The market value of their outstanding shares is at $10.7 million.
- Akso Health Group AHG shares rose 18.9% to $1.95. The company's market cap stands at $44.5 million.
- OpGen OPGN stock rose 18.03% to $0.4. The market value of their outstanding shares is at $4.0 million.
Losers
- Revelation Biosciences REVB stock decreased by 59.7% to $3.55 during Thursday's pre-market session.
- OneMedNet ONMD shares fell 24.34% to $1.43. The company's market cap stands at $46.1 million.
- Bullfrog AI Hldgs BFRG shares fell 20.09% to $3.9. The market value of their outstanding shares is at $23.7 million.
- Jin Medical International ZJYL stock decreased by 18.83% to $214.5. The market value of their outstanding shares is at $1.6 billion.
- Trinity Biotech TRIB shares fell 14.56% to $0.5. The market value of their outstanding shares is at $19.2 million. The company's, Q3 earnings came out yesterday.
- 180 Life Sciences ATNF stock declined by 12.15% to $0.19. The company's market cap stands at $1.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ATNF180 Life Sciences Corp
$1.83-5.67%
BFRGBullfrog AI Holdings Inc
$2.11-%
ERNAEterna Therapeutics Inc
$0.2452-0.93%
HOOKHOOKIPA Pharma Inc
$2.14-%
KPRXKiora Pharmaceuticals Inc
$3.13-3.37%
ONMDOneMedNet Corp
$1.4336.2%
OPGNOpGen Inc
--%
REVBRevelation Biosciences Inc
$0.3100-1.46%
SLRXSalarius Pharmaceuticals Inc
$1.474.26%
TRIBTrinity Biotech PLC
$0.83908.96%
ZJYLJin Medical International Ltd
$0.86001.19%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in